The Decision You're Facing
Your compliance program was built to address your organization's known risks, but the False Claims Act (FCA) is expanding into areas you might not have anticipated. The Civil Rights Fraud Initiative announced in May targets DEI programs receiving federal funding. A new DOJ-HHS working group formed in July is encouraging whistleblowers to report healthcare and life sciences violations. An August trade task force is urging reports on tariff evasion.
You need to decide: should you redesign parts of your compliance program now to address FCA exposure, or continue monitoring these developments before making structural changes?
This isn't just theoretical. If your organization receives federal funding, operates in healthcare, or manages international trade, you must decide whether to act now or wait for clearer enforcement patterns.
Key Factors That Affect Your Choice
Your Federal Funding Footprint
Organizations that receive federal contracts, grants, or reimbursements face direct FCA exposure. If federal dollars are involved in your DEI programs, research initiatives, or patient care operations, you're in scope for the new enforcement priorities.
Your Sector's Whistleblower Activity
Healthcare and life sciences have always generated significant qui tam actions under the FCA. The July working group explicitly encouraged whistleblowers to file in areas like Medicare Advantage, drug and device pricing, and barriers to patient access. If you operate in these spaces, you're already a target.
Your Current Controls Around Federal Representations
The FCA applies when you make false claims to the government. Review what your organization certifies when it accepts federal funds or submits claims. Do your controls verify that those certifications remain accurate throughout the contract or program period?
Your Internal Reporting Culture
Employees who see potential fraud have options. They can report internally, or they can file a qui tam action and potentially collect a percentage of any recovery. If your speak-up program doesn't inspire confidence, you won't hear about problems until the DOJ does.
Path A: Redesign Now if You Have Direct Exposure
Choose this path if:
- You receive federal funding for programs that could be scrutinized under the Civil Rights Fraud Initiative.
- You operate in healthcare or life sciences sectors named in the July working group announcement.
- You handle international trade and tariff classifications.
- Your compliance program hasn't been updated to address FCA-specific risks.
What This Looks Like in Practice:
Start with your certifications. Every time your organization accepts federal money or submits a claim, you're making representations about compliance with various laws. Map those representations, then verify that you have controls to ensure ongoing accuracy.
For DEI programs receiving federal funding, review whether any elements could be characterized as violating antidiscrimination laws. This doesn't mean abandoning DEI work. It means ensuring your programs comply with Title VI, Title VII, and other civil rights statutes that govern federal funding recipients.
For healthcare organizations, focus on the areas the working group highlighted. If you participate in Medicare Advantage, examine your risk adjustment practices. If you price drugs or devices, review your reporting to federal healthcare programs. If you manage prior authorization or formulary access, assess whether those processes could create barriers that violate program requirements.
Add FCA-specific scenarios to your risk assessment. The statute's qui tam provisions mean employees can become plaintiffs. Your risk isn't just regulatory enforcement but also whistleblower actions filed under seal.
Path B: Monitor and Prepare if Exposure is Indirect
Choose this path if:
- Your federal funding is limited and doesn't touch the newly scrutinized areas.
- You don't operate in healthcare, life sciences, or international trade.
- Your compliance program already addresses government contracting and grant compliance.
- You have strong internal reporting channels and investigation processes.
What This Looks Like in Practice:
You don't need to redesign your program, but you should strengthen your monitoring. Assign someone to track FCA enforcement actions in your industry. The DOJ publishes settlements and qui tam statistics. Watch for patterns.
Use this time to test your internal reporting system. Would an employee who discovered potential fraud feel comfortable reporting it internally? Or would they conclude their only option is filing a qui tam action? The difference matters because you can fix problems identified through internal channels before they become government investigations.
Review your training on government contracting and grants management. Make sure employees who interact with federal programs understand what constitutes a false claim. The FCA doesn't require intent to defraud; knowing or reckless disregard for truth is enough.
Document your monitoring process. If enforcement priorities shift toward your sector, you'll want evidence that you were tracking developments and updating your program accordingly.
Path C: Immediate Action if You've Identified a Gap
Choose this path if:
- You've discovered a certification you can't verify.
- An internal report suggests potential FCA exposure.
- A recent audit revealed control weaknesses around federal claims or contracts.
What This Looks Like in Practice:
Stop and assess before the gap becomes a violation. If you've certified compliance with requirements you can't verify, you need legal counsel immediately. The FCA's treble damages and per-claim penalties make this expensive to get wrong.
If an employee has raised concerns about federal billing, pricing, or program compliance, treat it as high priority. The same employee who reported internally could file a qui tam action if they don't see a meaningful response.
Engage outside counsel with FCA experience to evaluate your exposure. They can help you determine whether you need to make a voluntary disclosure, implement corrective action, or both.
Summary Matrix
| Your Situation | Recommended Path | First Action |
|---|---|---|
| Federal funding + named sector (DEI, healthcare, trade) | Path A: Redesign now | Map all federal certifications and verify controls |
| Limited federal funding, different sector | Path B: Monitor and prepare | Assign FCA enforcement tracking responsibility |
| Known gap in federal compliance controls | Path C: Immediate action | Engage FCA counsel for exposure assessment |
| Strong controls, no current exposure | Path B: Monitor and prepare | Test internal reporting effectiveness |
| Recent whistleblower concern raised | Path C: Immediate action | Investigate thoroughly and document response |
The FCA's expansion into new areas doesn't mean every organization faces immediate risk. But if you receive federal funding or operate in newly scrutinized sectors, waiting for enforcement actions against others in your industry is an expensive way to learn what the government expects. Your compliance program should address the risks you actually face, and those risks just expanded.
